|
|
|
40
|
A6812
|
COMBIVIR 150MG | 300MG TAB (GSK/COL) LAMIVUDINE | ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
COMBIVIR
|
60'S
|
BL
|
135.02
|
2.25
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2022-05-31
|
Delete from contract
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-04-19
|
|
|
|
41
|
A6812
|
COMBIVIR 150MG|300MG TAB (GSK) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
COMBIVIR
|
60'S
|
BL
|
149.83
|
2.4972
|
TAB
|
60
|
BOX
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
A681BN
|
KIVEXA 600MG | 300MG TAB (GSK/COL) ABACAVIR | LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
KIVEXA
|
30'S
|
BL
|
162.04
|
5.40
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681FC
|
KIVALA 600MG | 300MG TAB (REM/SBI) ABACAVIR | LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
KIVALA
|
30'S
|
BL
|
82.72
|
2.76
|
TABLET
|
0
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
42
|
A681FC
|
KIVALA 600MG|300MG TAB (REM) ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
KIVALA
|
30'S
|
BL
|
57.49
|
1.92
|
TAB
|
30
|
BLIS
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIRETROVIRALS MISCELLANEOUS
|
|
|
|
|
42
|
A681GQ
|
ABACAVIR|LAMIVUDINE 600MG|300MG TAB (CIP)
|
ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
30'S
|
BL
|
183.46
|
6.12
|
TAB
|
30
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
40
|
A681HB
|
ZOVILAM 150MG | 300MG TAB (MAT/AHI) LAMIVUDINE | ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
ZOVILAM
|
60'S
|
BL
|
21.20
|
0.35
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HB
|
ZOVILAM 150MG|300MG TAB (MAT) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
ZOVILAM
|
60'S
|
BL
|
30.17
|
0.5029
|
TAB
|
60
|
BOX
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
40
|
A681HE
|
ABACAVIR | LAMIVUDINE 600MG | 300MG TAB (MAT/AHI)
|
ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
30'S
|
BL
|
63.61
|
2.12
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
A681HG
|
DUOVIR 150MG | 300MG TAB (CIP/AHI) LAMIVUDINE | ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
DUOVIR
|
60'S
|
BL
|
53.47
|
0.89
|
TABLET
|
0
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180892
|
ANTIRETROVIRALS MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
A681HS
|
DUOVIR 150MG|300MG TAB (CIP) LAMIVUDINE|ZIDOVUDINE (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
DUOVIR
|
700'S
|
BL
|
119.14
|
0.1702
|
TAB
|
60
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HT
|
LAMIVUDINE|ZIDOVUDINE 150MG TAB (MCP) (BL)
|
LAMIVUDINE|ZIDOVUDINE
|
LAMIVUDINE|ZIDOVUDINE
|
60'S
|
BL
|
19.98
|
0.333
|
TAB
|
60
|
BOX
|
MCP
|
MACLEODS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081892
|
ANTIVIRALS, MISCELLANEOUS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
ANTIVIRALS, MISCELLANEOUS
|
|
|
|
|
41
|
A681HX
|
TRIUMEQ 600MG|50MG|300MG TAB (GSK) ABACAVIR|DOLUTEGRAVIR|LAM (BQ)
|
ABACAVIR|DOLUTEGRAVIR|LAMIVUDINE
|
TRIUMEQ
|
30'S
|
BQ
|
815.5
|
27.1833
|
TAB
|
0
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180812
|
INTEGRASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
INTEGRASE INHIBITORS
|
|
|
|
|
42
|
A681ZZ
|
ABACAVIR|LAMIVUDINE 600MG|300MG TAB (MAT)
|
ABACAVIR|LAMIVUDINE
|
ABACAVIR|LAMIVUDINE
|
30'S
|
BL
|
71.76
|
2.39
|
TAB
|
30
|
BOTT
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2026-04-01
|
|
|
ORAL
|
0
|
NRTI
|
|
|
|
|
40
|
B011DK
|
3TC 150MG TAB (GSK/COL) LAMIVUDINE
|
LAMIVUDINE
|
3TC
|
60'S
|
BL
|
42.84
|
0.71
|
TABLET
|
0
|
TAB
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
B011EG
|
APO-LAMIVUDINE 150MG TAB (APO/COL)
|
LAMIVUDINE
|
APO-LAMIVUDINE
|
60'S
|
B
|
83.02
|
1.3837
|
TABLET IMMED
|
|
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
|
8180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
Oral
|
|
NRTI
|
2022-12-09
|
|
|
|
42
|
B011EG
|
APO-LAMIVUDINE 150MG TAB (APO) LAMI
|
LAMIVUDINE
|
APO-LAMIVUDINE
|
60'S
|
BL
|
88.35
|
1.47
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
|
08180820
|
NRTI
|
2026-04-01
|
|
|
ORAL
|
0
|
NRTI
|
|
|
|
|
40
|
B011EK
|
LAMIVUDINE 150MG TAB (MAT/AHI)
|
LAMIVUDINE
|
LAMIVUDINE
|
30'S
|
BL
|
11.42
|
0.38
|
TABLET
|
0
|
TAB
|
MAT
|
MYLAN LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
B011EP
|
APO-LAMIVUDINE 150MG TAB (APO) LAMI (BL)
|
LAMIVUDINE
|
APO-LAMIVUDINE
|
60'S
|
BL
|
75.57
|
1.2595
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
08180820
|
NRTI
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
NRTI
|
|
|
|
|
42
|
B011ES
|
JONVIR 150MG TAB (JLP) LAMIVUDINE
|
LAMIVUDINE
|
JONVIR
|
30'S
|
BL
|
32.62
|
1.09
|
TAB
|
60
|
BLIS
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08180820
|
NRTI
|
2026-04-01
|
|
|
ORAL
|
0
|
NRTI
|
|
